New Zealand approved psychedelic therapy. Only one doctor can do it.

Lacey was chosen because of his extensive experience in safely using psilocybin for psychiatric treatment during clinical trials, according to the health ministry. He said that in 2021, he started looking into a psilocybin clinical trial after he noticed that many of his patients were not responding to antidepressant medications. The approval from New Zealand’s health ministry is the latest boost to a growing global movement to study and use psychedelics like psilocybin and MDMA — long relegated to the fringes of psychiatry — to treat depression, post-traumatic stress disorder,...